Analysis Heyu Biological Technology Corporation (HYBT)
5/29/2024
Analysis of Heyu Biological Technology Corporation (HYBT)
Heyu Biological Technology Corporation (HYBT) has been showing some interesting price movements recently. The stock closed at 0.34330 on January 19th, with the RSI indicator at 54.18859, indicating a neutral sentiment. The MACD indicator was slightly negative at -0.01554, with the MACD line below the signal line.Looking at the historical data, we can see that the stock has been quite volatile, with price fluctuations between 0.20140 and 0.40000 in the past few days. The moving averages (SMA, EMA, WMA) have been relatively close to each other, suggesting a lack of strong trend direction.
Overall, Heyu Biological Technology Corporation seems to be experiencing some uncertainty in its price movements, with no clear trend emerging. Traders and investors may want to closely monitor the stock for any potential breakout or reversal signals before making any trading decisions.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company over the specified periods.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.5%
- The next quarter growth rate is 4.8%
- The current quarter growth rate is 5.6%
- The next year growth rate is 9.7%
- The next 5 years compound annual growth rate (CAGR) is 11%
- The past 5 years compound annual growth rate (CAGR) is 20.15%
We can see that the company is expected to experience a significant increase in growth compared to the past 5 years, with a particularly strong growth rate projected for the next 5 years. This indicates positive expectations for the company's performance and potential expansion in the future.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast of $200. However, it's important to note that there is a wide range of forecasts, from $164 to $250. The current price of the security is below both the average and median forecast, suggesting that there may be potential for growth according to analysts.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The results for the quarter ending on January 31, 2025, were released after hours. The results for the quarter ending on October 31, 2024, were not supplied. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has fluctuated between a fifty-two-week low and high, with a positive change over the period.
Valuation metrics show a relatively high PEG ratio and forward PE ratio, with the company's market capitalization and enterprise value being substantial. The price to book and price to sales ratios are also on the higher side, indicating potential overvaluation.
The stock price summary includes beta, moving averages, and the range of prices over the past year. Dividends and splits data show the company's dividend history, payout ratio, and dividend yield metrics.
Overall, the data provides a comprehensive overview of the company's financial performance, stock metrics, valuation, stock price trends, and dividend policies.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales have been increasing over the years, from $274.52 billion in 2020 to $383.29 billion in 2023.
2. The gross profit margin has been fluctuating, with the highest in 2023 at $169.15 billion and the lowest in 2020 at $104.96 billion.
3. Operating income has also been varying, with the highest in 2023 at $114.30 billion and the lowest in 2020 at $66.28 billion.
4. Net income has shown an increasing trend, reaching $96.99 billion in 2023 from $57.41 billion in 2020.
5. Earnings per share (EPS) have been relatively stable, with slight fluctuations over the years.
6. The company has been able to maintain a consistent number of outstanding shares.
7. Overall, the financial performance of the company has been positive, with increasing revenues and net income over the years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated but generally show an increasing trend.
3. Non-current assets have also been increasing steadily.
4. Total liabilities have been increasing, with a slight decrease in 2019.
5. Shareholders' equity has been increasing over the years.
6. The company has been investing more in non-current assets compared to current assets.
7. There is a consistent amount of debt in the company's capital structure.
8. The company has been retaining earnings and increasing shareholders' equity.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with some fluctuations in different areas that may require further analysis.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, which is higher than the EPS of $1.26 from the same quarter a year ago. The range of estimates is between $1.27 and $1.36, as provided by 26 analysts.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, compared to $1.46 from the previous year. The estimates range from $1.44 to $1.63, based on 25 analysts' forecasts.
3. Looking at the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, higher than the previous year's EPS of $6.13. The analysts' estimates range from $6.43 to $6.92, with insights from 39 analysts.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, with a range of estimates between $6.40 and $7.90. This forecast is based on the input of 39 analysts.
Overall, the analysts are predicting an increase in earnings per share for both the current and next fiscal years, indicating positive growth prospects for the company.
MACD of HYBT
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
